Teodoro Bottiglieri serves as the Center Director of Research at Baylor Scott & White Research Institute (BSWRI), where he brings over 30 years of experience in laboratory-based techniques that are pivotal for advancing research and diagnostic biomarkers. His expertise lies in targeted metabolomics, particularly utilizing...
Teodoro Bottiglieri serves as the Center Director of Research at Baylor Scott & White Research Institute (BSWRI), where he brings over 30 years of experience in laboratory-based techniques that are pivotal for advancing research and diagnostic biomarkers. His expertise lies in targeted metabolomics, particularly utilizing liquid chromatography mass-spectrometry (LC-MS) techniques to explore complex metabolic pathways. Dr. Bottiglieri's current research focuses on critical areas such as homocysteine, folate, and vitamin B12 metabolism, as well as the role of S-adenosylmethionine in methylation processes associated with metabolic disorders. His work is particularly relevant in understanding inherited disorders that affect neurotransmitter metabolism and identifying risk factors for vascular and neurodegenerative diseases.
In his role at BSWRI, Dr. Bottiglieri oversees the integration of research activities across various core laboratories, including genomic, proteomic, and metabolic facilities. This collaborative environment fosters innovation and enhances the potential for groundbreaking discoveries in biomarker discovery and drug development. His leadership not only emphasizes the importance of interdisciplinary approaches but also ensures that cutting-edge technologies are effectively utilized to translate research findings into clinical applications.
Dr. Bottiglieri's extensive skill set encompasses animal testing, clinical trials, and biotechnology, positioning him as a key figure in the advancement of clinical development strategies. His commitment to bridging the gap between laboratory research and clinical practice is evident in his efforts to interface research across disciplines, ultimately aiming to improve patient outcomes through enhanced understanding of metabolic and genetic factors influencing health.
